Company
ClostraBio
Targeted Metabolite Delivery to Transform Intestinal Health
Also known as CLOSTRABIO, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- D2C
- Legal name
- CLOSTRABIO, INC.
Claim, correct or request removal
Record updated 28 September 2026
About
ClostraBio is pioneering next-generation probiotics for gut health, and advanced metabolite delivery solutions for inflammatory bowel disease (IBD) and food allergy.
Funding snapshot
- Total raised
- $9.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $9.9M2022-09-12
Funding rounds
- Round, 2022
- $9.9M2022-09-12, SEC form D sold, 15 investors
Loading relationship preview